Navigation Links
Acquisitions, Clinical Trial Results, Date Extensions and Financial Results - Research Report on Endo, Astex, Auxilium, Accuray, and BioScrip
Date:9/2/2013

: [http://www.investorsreports.com/report/2013-08-28/ENDP]

--

Astex Pharmaceuticals, Inc. Research Report

On August 28, 2013, Astex Pharmaceuticals, Inc. (Astex) reported topline results from the ongoing Phase 2 trial of SGI-110 in patients with AML and MDS. The Company stated that as of the end of the June 2013 data cutoff, 67 AML patients had a minimum follow up of 3 months (50 patients representing the complete cohort of relapsed/refractory AML, and 17 patients in the treatment-naïve elderly AML not suitable for induction chemotherapy cohort). According to Astex, the primary endpoint was overall remission rate (Complete Remission or CR Complete Remission with Incomplete hematologic recovery or CRi/CRp), and there were 8 remissions in relapsed/refractory AML and 9 remissions in treatment-naïve elderly AML for an overall complete remission rate of (CR, CRi/CRP0 of 17/67) or 25%. The Full Research Report on Astex Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-08-28/ASTX]

--

Auxilium Pharmaceuticals, Inc. Research Report

On August 28, 2013, Auxilium Pharmaceuticals, Inc. (Auxilium) announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it is extending the Prescription Drug Fee User Act (PDUFA) goal date for the Company's supplemental biologics license application (sBLA) for XIAFLEX (collagenase clostridium histolyticum) for the treatment of Peyronie's disease (PD) from September 6, 2013 to December 6, 2013. Commenting on the extension, Adrian Adams, CEO and President of Auxilium Pharmaceuticals, said, "While we are disappointed in any delay of approval, we remain confident in the XIAF
'/>"/>

SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Verum.de Exhibits at Outsourcing in Clinical Trials Southern California
2. Leading the Site CTMS Market: Clinical Conductor CTMS Reaches 1,600 Sites
3. Clinovo Sponsors Outsourcing in Clinical Trials Southern California Conference 2013, in La Jolla (CA), September 24-25
4. Mytrus Electronic Informed Consent System Selected for 2013 Product Leadership Award in Clinical Trials
5. In Vitro Safety Screening for Clinical Liabilities, New Life Science Webinar hosted by Xtalks
6. ACRES Launches Global Clinical Research Network Technology Platform
7. Oncopeptides Initiates Phase II Clinical Study with Melflufen in the Treatment of Multiple Myeloma Patients
8. Indiana University Contracts with Virtify for Clinical Trial Disclosure Solutions
9. LabAnswer and OpGen Implement the STARLIMS Cloud Platform to Support OpGen’s CLIA Certified Clinical Services Laboratory in Under Four Months
10. Study Scavenger and CenterWatch Partner to Improve Patient Recruitment, Enrollment and Mobile Access to Clinical Trials with New Study Scavenger Smartphone App
11. MD Biosciences Offers IL-23-Induced Psoriasis-Like Preclinical Model for Skin Inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 21, 2014 Prominent academics, leaders ... gather on December 3rd at Genetic Rx, a ... GeneticRx will take place at the Joseph B. ... will discuss the present and future of genetic ... and gene editing—as well as the treatment of ...
(Date:11/22/2014)... 2014 RURO, Inc., a leading ... released Limfinity® version 5.1.4. , RURO’s deployment teams ... than ever in RURO’s 8 year history. Many ... enhancement. Limfinity® version 5.1.4 is the perfect example ... bug fixes! , Limfinity® 5.1.4 release highlights – ...
(Date:11/22/2014)... November 22, 2014 The “Chiral ... Preparative), by Material (Metal, Glass, Plastic), by Application ... SFC] - Forecast to 2018” analyses and studies ... in North America, Europe, Asia, and Rest of ... and 15 figures spread through 135 pages and ...
(Date:11/22/2014)... -- The element of surprise has been a major advantage ... warning. Until now, epidemiologists had nothing to measure that ... in suboptimal responses to both the H1N1 pandemic of ... - http://photos.prnewswire.com/prnh/20141121/160242 That virus ... gene structural changes have been found that invariably to ...
Breaking Biology Technology:Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2RURO Announces Limfinity® version 5.1.4 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5Viruses' Advantage of Surprise is Lost 2
... for low-cost, small-size, high-speed, highly functional and high ... GHz radio chipsets in semiconductor technology have received ... board solutions are not able to meet the ... GHz frequency band, while the conventional antenna designs ...
... Prior LOI and Acquires Profitable Holding Company to Strengthen ... and Retail Presence, Acquires Research and Product Development Company to Expedite ... ... Scheduled for October 22, 2008 at 8:00 am E.T., NEW YORK, Oct. ...
... Mich., Oct. 21 October 31 is the last ... the state,s,largest and premier gathering of biosciences professionals in ... and 19 at the Rock Financial,ShowPlace in Novi, MI. ... the,association for the biosciences industry in Michigan., Exhibit ...
Cached Biology Technology:NTU and SIMTech announce the first antenna-in-package solution for single-chip 60 GHz radio 2American Oriental Bioengineering Completes Two Acquisitions 2American Oriental Bioengineering Completes Two Acquisitions 3American Oriental Bioengineering Completes Two Acquisitions 4Early-Bird Pricing Ends Soon for MichBio Expo Attendees and Exhibitors; Award Nominations Due Nov. 1 2
(Date:11/15/2014)... , Nov. 13, 2014  While we may still be ... McCoy used in "Star Trek" to gain instant access to ... to work with smartphones and tablets for monitoring and measuring ... healthcare world. This may seem a tad Orwellian to some, ... adopt some of these technological opportunities into their healthcare regime. ...
(Date:11/11/2014)...  Forensicon, Inc., a Chicago -based ... the promotion of Yaniv Schiff from Senior ... Schiff,s new role as Director, he will lead company ... examiners and provide leadership within the company,s digital forensics ... Schiff joined Forensicon in 2006 ...
(Date:11/7/2014)... Researchers led by Dr. Debra Auguste, associate professor, ... at The City College of New York, have ... treatment for one of the most aggressive forms ... (TNBCs) have a high mortality rate owing to ... effective therapeutic options. However, Professor Auguste,s team, discovered ...
Breaking Biology News(10 mins):Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2
... 18-acre ragweed field sounds like a sneezy, red-eyed zone ... The Johns Hopkins University, the parcel presented a rare ... grow, reproduce and scatter their pollen under varying weather ... high-tech and low-tech tools, could lead to better ways ...
... from the University of Exeter and Shimane University in ... C is essential for plant growth. This discovery could ... vitamin C dietary supplements. The study, which is ... newly-identified enzyme, GDP-L-galactose phosphorylase, which produces vitamin C, or ...
... Strengthened with Clinical ... Data Management, WHIPPANY, N.J. and ATLANTA, Sept. ... agreed to terms to acquire Zurich,Biostatistics, Inc. (ZBI). ... submissions, the acquisition further strengthens,ISI,s Clinical Data Interchange ...
Cached Biology News:Ragweed research is nothing to sneeze at 2Ragweed research is nothing to sneeze at 3Ragweed research is nothing to sneeze at 4Study shows vitamin C is essential for plant growth 2Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 2Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 3